Robert Blank
About Robert Blank
Robert Blank is the Vice President of Strategy for Worldwide Commercial Oncology at Bristol Myers Squibb, with extensive experience in oncology and pharmaceutical marketing from his tenure at Merck.
Title: Vice President Strategy Worldwide Commercial Oncology
Robert Blank holds the position of Vice President Strategy - Worldwide Commercial Oncology at Bristol Myers Squibb. He is based in Princeton, New Jersey, United States. In this role, he is responsible for devising and implementing strategies aimed at the commercial aspect of oncology treatments, enhancing the company's foothold in the global oncology market.
Professional Background at Merck
Robert Blank has an extensive background with Merck, spanning various high-level roles over more than two decades. Beginning as a Director of Global Business Development from 1992, he went on to manage several pivotal departments such as Marketing Operations, Business Info and Research, and Worldwide Marketing. His roles expanded across multiple regions, including Japan, where he served as the Regional Marketing Leader and Senior Director of Marketing. Notably, he was the Head of Marketing, Oncology, in Tokyo for four years, and later became the Global Disease Area Head - Oncology.
Education and Expertise
Robert Blank earned an MBA in Finance from Columbia Business School, which he attended from 1986 to 1988. He completed his undergraduate studies at Haverford College, where he studied from 1980 to 1984. His educational background laid a strong foundation for his career in business development, financial evaluation, and marketing strategy in the pharmaceutical industry.
Experience in the Japanese Pharmaceutical Market
Robert Blank has extensive experience in the Japanese pharmaceutical market, having worked in Japan for a decade. He held key positions such as Executive Director of Primary Care Marketing and Head of Marketing, Oncology. During his tenure, he managed significant marketing budgets and led the launch of noteworthy drugs, including the breakthrough cancer treatment Keytruda. He was instrumental in developing strategic drug positioning and building local teams to adapt to competitive environments.
Building and Leading International Teams
Throughout his career, Robert Blank has built and led effective teams across various regions, including Japan and Latin America. His efforts in developing international talent and local market teams significantly contributed to the operational success and market presence of the pharmaceutical companies he has worked for. This includes managing seven-figure marketing budgets and ensuring strategic alignment across diverse markets.